DataMeds AI Extinguishes $19M Liability, Confirms Equity Above Nasdaq Minimum
MEDS has more than doubled off its 52-week low of $0.823 on light trading volume (0.1× avg).
Summary
DataMeds AI confirms stockholders' equity above $2.5M, extinguishes $19M in liability from the MIPA settlement, and issues 666,667 shares to REBOOT Health AI for a care management platform license valued at $2,000,000, with additional shares if the 180-day market value falls below $2M and $50,000 paid toward reconfiguration.
Updated with an SEC 8-K filing · What changed
Updates
· SEC 8-K — DataMeds licensed REBOOT Health AI platform for 666,667 shares valued at $2,000,000, with additional shares if 180-day market value falls below $2M; paid $50,000 toward reconfiguration.
Key Events · Legal and Risk Events · MEDS
-
Updated · · SEC 8-K
REBOOT License Agreement
Issued 666,667 shares of common stock to REBOOT Health AI, Inc. for a care management platform license to integrate into its business model, valued at $2,000,000, with additional shares if the 180-day market value falls below $2M; paid $50,000 toward reconfiguration.
-
Equity Threshold Confirmed
Stockholders' equity now exceeds $2,500,000, addressing the Nasdaq delisting risk previously disclosed in the Q2 2026 10-Q.
-
$19M Liability Extinguished
The MIPA settlement extinguished approximately $19 million in liability from the consolidated balance sheet, materially improving the company's financial position.
-
Settlement Terms Recap
Paid $450,000 total — $350,000 for repurchase of 364,099 shares and $100,000 for settlement of MIPA claims, as previously disclosed on 2026-09-17.
Analysis · MEDS · Trade & Services
DataMeds AI confirms stockholders' equity now exceeds $2.5 million, directly addressing the Nasdaq delisting risk flagged in its Q2 2026 10-Q. The settlement with the MIPA parties extinguished approximately $19 million in balance-sheet liability — a material cleanup that removes a going-concern overhang. In exchange for a care management platform license valued at $2,000,000, the company issued 666,667 shares to REBOOT Health AI, adding modest dilution but bringing operational capability; additional shares are due if the 180-day market value falls below $2M, and $50,000 was paid toward reconfiguration.
How filings like this one have moved
In the 30 days to Oct 16, 2026, 36.9% of the 961 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MEDS was trading at $3.01 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $9.6M. The 52-week trading range was $0.82 to $73.00. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.